EMVision had its EMView study published in npj Digital Medicine, a Nature Portfolio journal, validating the AI models behind its RF brain scanner. The peer-reviewed results show the scanner can distinguish haemorrhagic from ischaemic stroke with high sensitivity and specificity, an invaluable distinction, as the two stroke types require opposite treatments. The publication supports the Australian company's point-of-care and prehospital programs and adds new patents to its portfolio.